((2S,3R,4S,5S)-5-(2-BROMO-5,6-DICHLOROBENZIMIDAZOL-1-YL)-3,4-DIHYDROXYOXOLAN-2-YL)METHYL ACETATE
UNII YV6YF73KMS

Substance Identification & Data

This profile provides standardized clinical and technical data for ((2s,3r,4s,5s)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YV6YF73KMS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
YV6YF73KMS
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
((2S,3R,4S,5S)-5-(2-BROMO-5,6-DICHLOROBENZIMIDAZOL-1-YL)-3,4-DIHYDROXYOXOLAN-2-YL)METHYL ACETATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C14H13BrCl2N2O5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
JQTRQRCKNSMTRD-CYDGBPFRSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
53969707
Unique identification number in the NCBI database of chemical substances.
Substance Type
[(2S,3R,4S,5S)-5-(2-Bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl acetate
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
CC(=O)OC[C@H]1[C@@H]([C@@H]([C@@H](n2c3cc(c(cc3nc2Br)Cl)Cl)O1)O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for ((2s,3r,4s,5s)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

[(2S,3R,4S,5S)-5-(2-Bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl acetate

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound